Cardiometabolic Effects of Aerobic Exercise Plus Breaking Sitting
- Conditions
- Sedentary BehaviourSedentary Time
- Interventions
- Other: Aerobic exercise+2 minutes of walking breaks every 30 minutesOther: Aerobic exercise+8 minutes of walking breaks every 2-hOther: Aerobic exercise+6.5 h of prolonged sittingOther: Aerobic exercise+4 minutes of walking breaks every 1-h
- Registration Number
- NCT06106464
- Lead Sponsor
- Yasin Ak
- Brief Summary
The goal of this randomized crossover clinical trial is to investigate the effects of interrupting prolonged sitting with intermittent walks of equal volume but at different frequencies, in addition to moderate-intensity aerobic exercise, on postprandial serum lipid profile in young adults between the ages of 18-30. The main questions it aims to answer are:
* Do interrupting prolonged sitting with intermittent walks of equal volume but at different frequencies sustain positive cardiometabolic effects after moderate-intensity aerobic exercise?
* If "yes", which frequency of breaks is more effective to provide cardiometabolic benefits?
Participants will complete four conditions on separate days: 1) 6.5 hours of prolonged sitting after 30 minutes of moderate intensity aerobic exercise 2) breaking prolonged sitting with 2 minutes of walking every 30 minutes after 30 minutes of moderate intensity exercise 3) breaking prolonged sitting with 4 minutes of walking every 1-h after 30 minutes of moderate intensity exercise 4) breaking prolonged sitting with 8 minutes of walking every 2-h after 30 minutes of moderate intensity aerobic exercise.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 14
- Being between the ages of 18-30
- Being able to participate in physical activity
- More than 7 hours of daily sitting time measured subjectively
- Not exercising regularly in the last 3 months
- Hypertension
- Coronary heart disease
- Heart failure
- Diabetes mellitus
- Metabolic syndrome
- Obesity
- Hypothyroidism
- Non-alcoholic fatty liver disease
- Chronic inflammatory joint disease
- Chronic renal failure
- Cushing's syndrome
- HIV infection
- Being on antihypertensive medication
- Being on lipid-lowering medication
- Being on antidiabetic medication
- Being on systemic glucocorticoid medication
- LDL-cholesterol≥130 mg.dL-1
- HDL-cholesterol <40 mg.dL-1 for men; <50 mg.dL-1 for women
- Prediabetes
- Alcohol addiction
- Smoking
- Pregnancy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Aerobic exercise+2 minutes of walking breaks every 30 minutes Aerobic exercise+2 minutes of walking breaks every 30 minutes Participants will break prolonged sitting with 2 minutes of walking every 30 minutes after 30 minutes of moderate intensity aerobic exercise. Aerobic exercise+8 minutes of walking breaks every 2-h Aerobic exercise+8 minutes of walking breaks every 2-h Participants will break prolonged sitting with 8 minutes of walking every 2-h after 30 minutes of moderate intensity aerobic exercise. Aerobic exercise+6.5 h of prolonged sitting Aerobic exercise+6.5 h of prolonged sitting Participants will sit 6.5 hours after 30 minutes of moderate intensity aerobic exercise. Aerobic exercise+4 minutes of walking breaks every 1-h Aerobic exercise+4 minutes of walking breaks every 1-h Participants will break prolonged sitting with 4 minutes of walking every 1-h after 30 minutes of moderate intensity aerobic exercise.
- Primary Outcome Measures
Name Time Method Capillary glucose area under the curve During the four 7.5-hour intervention sessions samples will be collected at the 30th, 60th, 90th, 120th and 210th minutes after breakfast, and at the 30th, 60th, 90th, 120th and 210th minutes after lunch. Fasting and subsequent capillary blood glucose measurements will be carried out. Blood samples will be taken by pricking the tip of the distal phalanx of the right or left middle finger with a lancet. The first drop of blood will be wiped with cotton and the second drop of blood will be analyzed with a glucometer (GL 44, Beurer GmbH, Germany). Two consecutive measurements will be made and the average of both measurements will be recorded. For each 7.5-hour intervention, the total area under the curve (AUC) will be calculated for capillary glucose using the trapezoidal method. Incremental AUC will then be calculated by subtracting the area of baseline level from the total AUC.
Serum Low-Density Lipoprotein cholesterol area under the curve During the four 7.5-hour intervention sessions, 5 mL blood samples will be drawn at the 60th, 120th and 210th minutes after breakfast and at the 60th, 120th and 210th minutes after lunch Fasting venous blood samples for serum LDL cholesterol will be collected by inserting a cannula into the appropriate vein. The intravenous cannula will be fixed tightly with patch tape. Then fasting blood samples will be drawn. During each 7.5-hour intervention, 5 mL blood samples will be drawn at the 60th, 120th and 210th minutes after breakfast and at the 60th, 120th and 210th minutes after lunch from the intravenous cannula with a syringe. The blood samples taken into the syringe will be transferred to a yellow capped gel tube and the blood samples will be sent to the biochemistry laboratory for analysis.For each 7.5-hour intervention, the total AUC will be calculated for serum LDL cholesterol using the trapezoidal method. Incremental AUC will then be calculated by subtracting the area of baseline level from the total AUC.
Serum total cholesterol area under the curve During the four 7.5-hour intervention sessions, 5 mL blood samples will be drawn at the 60th, 120th and 210th minutes after breakfast and at the 60th, 120th and 210th minutes after lunch Fasting venous blood samples for serum total cholesterol will be collected by inserting a cannula into the appropriate vein. The intravenous cannula will be fixed tightly with patch tape. Then fasting blood samples will be drawn. During each 7.5-hour intervention, 5 mL blood samples will be drawn at the 60th, 120th and 210th minutes after breakfast and at the 60th, 120th and 210th minutes after lunch from the intravenous cannula with a syringe. The blood samples taken into the syringe will be transferred to a yellow capped gel tube and the blood samples will be sent to the biochemistry laboratory for analysis.For each 7.5-hour intervention, the total AUC will be calculated for serum total cholesterol using the trapezoidal method. Incremental AUC will then be calculated by subtracting the area of baseline level from the total AUC.
Serum High-Density Lipoprotein cholesterol area under the curve During the four 7.5-hour intervention sessions, 5 mL blood samples will be drawn at the 60th, 120th and 210th minutes after breakfast and at the 60th, 120th and 210th minutes after lunch Fasting venous blood samples for serum HDL cholesterol will be collected by inserting a cannula into the appropriate vein. The intravenous cannula will be fixed tightly with patch tape. Then fasting blood samples will be drawn. During each 7.5-hour intervention, 5 mL blood samples will be drawn at the 60th, 120th and 210th minutes after breakfast and at the 60th, 120th and 210th minutes after lunch from the intravenous cannula with a syringe. The blood samples taken into the syringe will be transferred to a yellow capped gel tube and the blood samples will be sent to the biochemistry laboratory for analysis.For each 7.5-hour intervention, the total AUC will be calculated for serum HDL cholesterol using the trapezoidal method. Incremental AUC will then be calculated by subtracting the area of baseline level from the total AUC.
Serum triglycerides area under the curve During the four 7.5-hour intervention sessions, 5 mL blood samples will be drawn at the 60th, 120th and 210th minutes after breakfast and at the 60th, 120th and 210th minutes after lunch Fasting venous blood samples for serum triglycerides will be collected by inserting a cannula into the appropriate vein. The intravenous cannula will be fixed tightly with patch tape. Then fasting blood samples will be drawn. During each 7.5-hour intervention, 5 mL blood samples will be drawn at the 60th, 120th and 210th minutes after breakfast and at the 60th, 120th and 210th minutes after lunch from the intravenous cannula with a syringe. The blood samples taken into the syringe will be transferred to a yellow capped gel tube and the blood samples will be sent to the biochemistry laboratory for analysis.For each 7.5-hour intervention, the total AUC will be calculated for serum triglycerides using the trapezoidal method. Incremental AUC will then be calculated by subtracting the area of baseline level from the total AUC.
- Secondary Outcome Measures
Name Time Method Systolic blood pressure During the four 7.5-hour intervention sessions, measurements will be carried out approximately at the 20th minute of each hour (10:20, 11:20, 12:20, 13:20, 14:20, 15:20, 16:20) Systolic blood pressures will be measured in the arm in the morning before each intervention and at regular intervals during each intervention. Measurements will be taken in an upright position just before blood samples are taken and after a rest period of at least 10 minutes from the last exercise bout. Blood pressure measurements will be taken with a digital blood pressure monitor (BM 40, Beurer GmbH, Germany) in the arm. The first measurement will be taken at approximately 08:30 a.m and the next 7 measurements will be carried out approximately at the 20th minute of each hour (10:20, 11:20, 12:20, 13:20, 14:20, 15:20, 16:20). Three measurements will be made at one-minute intervals and the average value of the three measurements will be recorded.
Diastolic blood pressure During the four 7.5-hour intervention sessions, measurements will be carried out approximately at the 20th minute of each hour (10:20, 11:20, 12:20, 13:20, 14:20, 15:20, 16:20) Diastolic blood pressures will be measured in the arm in the morning before each intervention and at regular intervals during each intervention. Measurements will be taken in an upright position just before blood samples are taken and after a rest period of at least 10 minutes from the last exercise bout. Blood pressure measurements will be taken with a digital blood pressure monitor (BM 40, Beurer GmbH, Germany) in the arm. The first measurement will be taken at approximately 08:30 a.m and the next 7 measurements will be carried out approximately at the 20th minute of each hour (10:20, 11:20, 12:20, 13:20, 14:20, 15:20, 16:20). Three measurements will be made at one-minute intervals and the average value of the three measurements will be recorded.
Trial Locations
- Locations (1)
Kastamonu University, Çatalzeytin Vocational School
🇹🇷Kastamonu, Turkey
Kastamonu University, Çatalzeytin Vocational School🇹🇷Kastamonu, Turkey